All Stories

  1. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, September 2016, Wiley

    Dr Marc H. Scheetz

  2. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr Marc H. Scheetz

  3. Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics

    Article • Infection Control, May 2016, Cambridge University Press

    Dr Marc H. Scheetz

  4. Pharmacokinetics of centhaquin citrate in a dog model

    Article • Journal of Pharmacy and Pharmacology, April 2016, Wiley

    Dr Marc H. Scheetz

  5. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  6. Carbapenem susceptibility breakpoints, clinical implications with the moving target

    Article • Expert Review of Anti-infective Therapy, March 2016, Informa Healthcare

    Dr Marc H. Scheetz

  7. Genome Sequences of Five Clinical Isolates of Klebsiella pneumoniae

    Article • Genome Announcements, March 2016, ASM Journals

    Dr Marc H. Scheetz

  8. Periarrest intestinal bacterial translocation and resuscitation outcome

    Article • Journal of Critical Care, February 2016, Elsevier

    Dr Marc H. Scheetz

  9. An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

    Article • Journal of Infection and Chemotherapy, February 2016, Elsevier

    Dr Marc H. Scheetz

  10. Implementing a Continuous or Prolonged Infusion Beta-Lactam Program in the Hospital Setting

    Article • January 2016, Springer Science + Business Media

    Dr Marc H. Scheetz

  11. Pharmacokinetics of centhaquin citrate in a rat model

    Article • Journal of Pharmacy and Pharmacology, January 2016, Wiley

    Dr Marc H. Scheetz

  12. Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  13. Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse

    Article • Antimicrobial Agents and Chemotherapy, November 2015, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  14. Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature

    Article • Journal of Infection and Chemotherapy, October 2015, Elsevier

    Dr Marc H. Scheetz

  15. The association of elevated trough serum vancomycin concentrations with obesity

    Article • Journal of Infection and Chemotherapy, July 2015, Elsevier

    Dr Marc H. Scheetz

  16. Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections

    Article • Antimicrobial Agents and Chemotherapy, June 2015, ASM Journals

    Dr Marc H. Scheetz

  17. Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC

    Article • Diagnostic Microbiology and Infectious Disease, June 2015, Elsevier

    Dr Marc H. Scheetz

  18. 636

    Article • Critical Care Medicine, December 2014, Wolters Kluwer Health

    Dr Marc H. Scheetz

  19. Projections for antiinfective drug shortages and time to actual resolution

    Article • American Journal of Health-System Pharmacy, November 2014, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  20. Knowledge and Attitudes of Doctor of Pharmacy Students Regarding the Appropriate Use of Antimicrobials

    Article • Clinical Infectious Diseases, September 2014, Oxford University Press (OUP)

    Dr Marc H. Scheetz

  21. Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages

    Article • Infectious Diseases and Therapy, September 2014, Springer Science + Business Media

    Dr Marc H. Scheetz

  22. Impact of Loading Doses on the Time to Adequate Predicted Beta-Lactam Concentrations in Prolonged and Continuous Infusion Dosing Schemes

    Article • Clinical Infectious Diseases, May 2014, Oxford University Press (OUP)

    Dr Marc H. Scheetz

  23. Unacceptably High Error Rates in Vitek 2 Testing of Cefepime Susceptibility in Extended-Spectrum-β-Lactamase-Producing Escherichia coli

    Article • Antimicrobial Agents and Chemotherapy, April 2014, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  24. Impact of vancomycin treatment duration and dose on kidney injury

    Article • International Journal of Antimicrobial Agents, March 2014, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  25. Novel Work Models Needed for Faculty Members Trying to Balance Clinical Practice With Scholarly Responsibilities

    Article • American Journal of Pharmaceutical Education, February 2014, American Journal of Pharmaceutical Education

    Marc Scheetz, Dr Marc H. Scheetz

  26. Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study to translate to patient outcomes

    Article • BMC Infectious Diseases, January 2014, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  27. Pathogenicity of Clinical Acinetobacter baumannii Isolates in a Galleria mellonella Host Model According toblaOXA-40Gene and Epidemiological Outbreak Status

    Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  28. Characterization of Ciprofloxacin Resistant Escherichia coli Isolates among Men Undergoing Evaluation for Transrectal Ultrasound Guided Prostate Biopsy

    Article • The Journal of Urology, December 2013, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  29. Effects on Patient Care Caused by Drug Shortages: A Survey

    Article • Journal of Managed Care Pharmacy, November 2013, Academy of Managed Care Pharmacy

    Dr Marc H. Scheetz

  30. Pharmacodynamic Target Attainment for Various Ceftazidime Dosing Schemes in High-Flux Hemodialysis

    Article • Antimicrobial Agents and Chemotherapy, September 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  31. Empty Shelves, Full of Frustration: Consequences of Drug Shortages and the Need for Action

    Article • Hospital Pharmacy, September 2013, Thomas Land Publishers

    Marc Scheetz, Dr Marc H. Scheetz

  32. Adherence to the 2009 Consensus Guidelines for Vancomycin Dosing and Monitoring Practices: A Cross-Sectional Survey of U.S. Hospitals

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, July 2013, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  33. Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  34. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions

    Article • American Journal of Health-System Pharmacy, June 2013, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  35. Virulence of Vancomycin-Resistant Enterococcus faecium According to Linezolid Resistance and Clinical Outbreak Status

    Article • Antimicrobial Agents and Chemotherapy, June 2013, ASM Journals

    Marc Scheetz, Dr Marc H. Scheetz

  36. Bacterial and Clinical Characteristics of Health Care- and Community-Acquired Bloodstream Infections Due to Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, June 2013, ASM Journals

    Dr Marc H. Scheetz

  37. Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project

    Article • Drug Safety, April 2013, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  38. Temporal changes in pulsed-field gel electrophoresis banding in vancomycin-resistant Enterococcus faecium and implications for outbreak investigations

    Article • American Journal of Infection Control, April 2013, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  39. Need for standardization in assessing impact of antibiotic shortages on patient outcomes

    Article • American Journal of Health-System Pharmacy, December 2012, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  40. Variability of cyclosporine concentrations by HPLC and TDX monoclonal assay methods, application of a correction factor, and description of a novel clinical approach to determine the practical consequences of changing assay technique

    Article • Clinical Transplantation, October 2012, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  41. An Analysis of the Accuracy of Physician-Entered Indications on Computerized Antimicrobial Orders

    Article • Infection Control, October 2012, Cambridge University Press

    Marc Scheetz, Dr Marc H. Scheetz

  42. Effective use of a clinical decision-support system to advance antimicrobial stewardship

    Article • American Journal of Health-System Pharmacy, August 2012, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  43. Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification

    Article • Antimicrobial Agents and Chemotherapy, July 2012, ASM Journals

    Dr Marc H. Scheetz

  44. Prospective Approach to Managing Antimicrobial Drug Shortages

    Article • Infection Control, July 2012, Cambridge University Press

    Marc Scheetz, Dr Marc H. Scheetz

  45. Antimicrobial Drug Shortages: A Crisis Amidst the Epidemic and the Need for Antimicrobial Stewardship Efforts to Lessen the Effects

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2012, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  46. Targeted Antimicrobial Prophylaxis Using Rectal Swab Cultures in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy is Associated With Reduced Incidence of Postoperative Infectious Complications and Cost of Care

    Article • The Journal of Urology, April 2012, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  47. The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes

    Article • Clinical Infectious Diseases, January 2012, Oxford University Press (OUP)

    Dr Marc H. Scheetz

  48. Antimicrobial stewardship programs: methods of operation and suggested outcomes

    Article • Expert Review of Anti-infective Therapy, January 2012, Informa Healthcare

    Marc Scheetz, Dr Marc H. Scheetz

  49. Pharmacokinetic Assessment of Peramivir in a Hospitalized Adult Undergoing Continuous Venovenous Hemofiltration

    Article • Annals of Pharmacotherapy, November 2011, SAGE Publications

    Dr Marc H. Scheetz

  50. Impact of Carbapenem Resistance and Receipt of Active Antimicrobial Therapy on Clinical Outcomes of Acinetobacter baumannii Bloodstream Infections

    Article • Antimicrobial Agents and Chemotherapy, August 2011, ASM Journals

    Dr Marc H. Scheetz

  51. Life-Years Gained with Meropenem over Ciprofloxacin in Penicillin-Allergic Patients with Gram-Negative Bacilli Sepsis: Results of a Probabilistic Model

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, May 2011, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  52. Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practice

    Article • International Journal of Clinical Pharmacy, March 2011, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  53. Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter Baumannii

    Article • Annals of Pharmacotherapy, February 2011, SAGE Publications

    Dr Marc H. Scheetz

  54. Biopsy-Proven Acute Tubular Necrosis due to Vancomycin Toxicity

    Article • International Journal of Nephrology, January 2011, Hindawi Publishing Corporation

    Marc Scheetz, Dr Marc H. Scheetz

  55. Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, December 2010, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  56. Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections

    Article • Antimicrobial Agents and Chemotherapy, October 2010, ASM Journals

    Dr Marc H. Scheetz

  57. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

    Article • Clinical Therapeutics, September 2010, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  58. The Impact of Qualitative Respiratory Cultures on Mortality in Critically Ill Patients With Hospital-Acquired Pneumonia

    Article • Hospital Pharmacy, August 2010, Thomas Land Publishers

    Marc Scheetz, Dr Marc H. Scheetz

  59. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients

    Article • International Journal of Antimicrobial Agents, July 2010, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  60. Predictability of Doripenem Susceptibility in Acinetobacter baumannii Isolates Based on Other Carbapenem Susceptibilities and bla OXA Gene Status

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2010, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  61. Cerebral Spinal Fluid Penetration of Tigecycline in a Patient with Acinetobacter baumannii Cerebritis

    Article • Annals of Pharmacotherapy, February 2010, SAGE Publications

    Dr Marc H. Scheetz

  62. Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring

    Article • Bone Marrow Transplantation, December 2009, Springer Science + Business Media

    Dr Marc H. Scheetz

  63. The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock

    Article • American Journal of Therapeutics, November 2009, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  64. Identification of Optimal Renal Dosage Adjustments for Traditional and Extended-Infusion Piperacillin-Tazobactam Dosing Regimens in Hospitalized Patients

    Article • Antimicrobial Agents and Chemotherapy, October 2009, ASM Journals

    Dr Marc H. Scheetz

  65. Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection

    Article • Diagnostic Microbiology and Infectious Disease, September 2009, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  66. Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa

    Article • Diagnostic Microbiology and Infectious Disease, August 2009, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  67. Morbidity associated with Pseudomonas aeruginosa bloodstream infections

    Article • Diagnostic Microbiology and Infectious Disease, July 2009, Elsevier

    Marc Scheetz, Dr Alan R Hauser, Dr Marc H. Scheetz

  68. Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use

    Article • Drug Safety, January 2009, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  69. Posaconazole: An Oral Triazole with an Extended Spectrum of Activity

    Article • Annals of Pharmacotherapy, August 2008, SAGE Publications

    Dr Marc H. Scheetz

  70. Characterization of Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains Collected from 2004 to 2007

    Article • Journal of Clinical Microbiology, January 2008, ASM Journals

    Dr Marc H. Scheetz

  71. Serum Piperacillin/Tazobactam Pharmacokinetics in a Morbidly Obese Individual

    Article • Annals of Pharmacotherapy, October 2007, SAGE Publications

    Dr Marc H. Scheetz

  72. Leukopenia Complicates Cytomegalovirus Prevention After Renal Transplantation With Alemtuzumab Induction

    Article • Transplantation, April 2007, Wolters Kluwer Health

    Marc Scheetz, Dr Marc H. Scheetz

  73. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy

    Article • Bone Marrow Transplantation, February 2007, Springer Science + Business Media

    Dr Marc H. Scheetz

  74. In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, February 2007, ASM Journals

    Dr Marc H. Scheetz

  75. 219: N-acetylcysteine administration for the prevention of the liver complications following allogeneic hematapoetic stem cell transplantation

    Article • Biology of Blood and Marrow Transplantation, February 2007, Elsevier

    Dr Marc H. Scheetz

  76. Systematic Review of Piperacillin-Induced Neutropenia

    Article • Drug Safety, January 2007, Springer Science + Business Media

    Marc Scheetz, Dr Marc H. Scheetz

  77. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci

    Article • Diagnostic Microbiology and Infectious Disease, December 2006, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  78. Peritoneal Fluid Penetration of Tigecycline

    Article • Annals of Pharmacotherapy, November 2006, SAGE Publications

    Dr Marc H. Scheetz

  79. Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Dr Marc H. Scheetz

  80. Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens

    Article • American Journal of Health-System Pharmacy, July 2006, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  81. Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2006, Wiley

    Marc Scheetz, Dr Marc H. Scheetz

  82. Comparison of Testing Methods for Detection of Decreased Linezolid Susceptibility Due to G2576T Mutation of the 23S rRNA Gene in Enterococcus faecium and Enterococcus faecalis

    Article • Journal of Clinical Microbiology, March 2006, ASM Journals

    Dr Marc H. Scheetz

  83. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia

    Article • Journal of Infection, February 2006, Elsevier

    Marc Scheetz, Dr Marc H. Scheetz

  84. Effect of on-call infectious-diseases pharmacists on antibiotic expenditures

    Article • American Journal of Health-System Pharmacy, October 2005, American Society of Health System Pharmacists

    Dr Marc H. Scheetz

  85. In vivo synergy of daptomycin plus a penicillin agent for MRSA?

    Article • Journal of Antimicrobial Chemotherapy, January 2005, Oxford University Press (OUP)

    Dr Marc H. Scheetz